We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Treatt Plc | LSE:TET | London | Ordinary Share | GB00BKS7YK08 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-6.50 | -1.33% | 483.50 | 481.00 | 491.50 | 494.50 | 475.00 | 475.00 | 88,037 | 16:35:23 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Chemicals & Chem Preps, Nec | 147.4M | 10.94M | 0.1809 | 27.11 | 296.62M |
Date | Subject | Author | Discuss |
---|---|---|---|
30/3/2015 13:01 | I do have a bit of concern about how long the rebuild / relocation decision seems to be taking. At y/e they spoke about having to spend significant sums to modernise and make legislatively compliant, the current premises over the next couple of years. A new plant cannot be knocked up in a couple of months and we are still only at the consultation stage, so the decision may be taken for them | housemartin2 | |
30/3/2015 12:24 | Yes and turning off the laptop now ) - employees would perhaps be the main stakeholders in this decision, well that was my take on reading. | essentialinvestor | |
30/3/2015 12:09 | It was the consulting with key stakeholders that puzzled me. Your'e supposed to be on holiday EI :-) apad | apad | |
30/3/2015 11:56 | There is a longer term need for new premises as indicated, a decision has yet to be taken whether to redevelop the current site or a greenfield option. This and the conclusion of the earn out dispute are reasons why the SP trades at these levels, hopefully an update on one or both of these at the half year or before. The CEO will usually reply to e-mails btw, if anyone requires more detailed information. For me risk/reward looks reasonable at around these levels, however as always DYOR. | essentialinvestor | |
30/3/2015 11:50 | Assume it means a sale or an expansion | hydrus | |
30/3/2015 11:19 | Anyone translate this last para? apad The Board have continued to actively consider a number of options with regard to its UK plant and facilities at Bury St Edmunds which no longer meet the medium to long term needs of the business as we pursue our strategy towards becoming an ingredient solutions partner of choice for both global and local FMCG businesses. Whilst formal plans are some way off, we expect to be in a position to consult with key stakeholders to ensure their support as these plans come together over the next 6-9 months. | apad | |
25/3/2015 13:45 | APAD, decent longer term price IMO, just off on holiday so quick reply. | essentialinvestor | |
25/3/2015 13:39 | Well, I seem to have become a follower, EI. I have bought a first holding (140.35p) - It'll be nice to have someone to blame :-) I like the moving up the value chain and I take the director buy seriously. apad | apad | |
24/3/2015 08:13 | Added some more. | essentialinvestor | |
23/3/2015 20:00 | top - 18/03 purchase. Today's CEO buy was not announced until 15.15, good to see another buy. | essentialinvestor | |
23/3/2015 19:15 | It was the CEO actually but still bullish as it wasn't a trivial purchase. | topvest | |
23/3/2015 12:16 | Chairman already holds a few, so good to see him add further. | essentialinvestor | |
19/3/2015 10:38 | But the biz is Sound and steady - added today. Happy. | loofyloofy | |
19/3/2015 09:46 | Just a few weeks ago I could not get hold of 500 shares online. | essentialinvestor | |
19/3/2015 08:59 | Added a few. | essentialinvestor | |
19/3/2015 01:52 | If, . . . . if only we knew! | jojaken | |
18/3/2015 21:13 | If pattern repeats itself then now is a good entry point | hydrus | |
13/2/2015 15:46 | Very difficult to buy in any quantity today. | essentialinvestor | |
28/1/2015 08:53 | Good timing EI, I should have taken advantage of your 20+ years relationship. apad | apad | |
21/1/2015 14:24 | also from 2012 Franc and fragrance Roesti suggests high costs associated with the franc was the reason Givaudan relocated a manufacturing plant from near Zurich to Hungary last year, although Wullschleger says it was a strategic decision to replace an old plant with a new one designed to cater to the eastern European market. However Wullschleger does concede that building the new plant in Switzerland would have been “far too expensive and strategically located in the wrong place. It’s production … and this you can do elsewhere. “I don’t want to play down the problem of the Swiss franc. When we consolidate in Swiss francs we have lost a lot of money, that is clear, but it’s only a translation problem, not a transaction problem because we produce very little in Switzerland,” says Wullschleger. “It’s distributed around the globe so costs and revenues are practically concurrent. There is no impact on the margin ... [the Swiss franc] is not attacking our competitiveness | haroldthegreat | |
21/1/2015 13:52 | very good point re swiss franc revaluation from 2012 They are the biggest flavour and fragrance companies in the world, dominating an estimated 30 - 40 per cent of markets. So why are Swiss firms Givaudan and Firmenich so successful? but will companies want to reformulate their ranges just to save 20% of something that is used =in very small quantities. | haroldthegreat | |
21/1/2015 13:43 | the directors cannot buy if the information to be announced is better than that given in previous rns. that would be inside trading. so you can assume that the information to be announced will be in line with previous rns. imho | haroldthegreat | |
21/1/2015 12:04 | AGM this Friday week, would assume they will tie this in with their IMS, so expect a trading update on the 30th of January imv. | essentialinvestor | |
20/1/2015 11:03 | The Swiss are major exporters of fragrances, the very significant rise in the CHF may be helpful to this part of Treat's business, just IMV only. | essentialinvestor | |
20/1/2015 10:49 | Added this AM. | essentialinvestor |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions